The National Kidney Foundation, the American Diabetes Association, and the American Society of Nephrology brought together experts in nephrology and endocrinology for a consensus conference that reviewed current practices and identified knowledge gaps, research opportunities, and ways to improve clinical outcomes related to diabetic kidney disease (DKD). The results were published by the American Diabetes Association.
DKD is one of the most frequent complications of both types of diabetes, and DKD is the leading cause of end-stage renal disease. The cost of care for patients with DKD is extremely high, and rates of this disease continue to rise in high-risk groups. Due to the high human and societal costs, the Consensus Conference on Chronic Kidney Disease and Diabetes was convened to address issues relating to patient management, current practices, and potential new directions.
The conference looked at seven majors topics of DKD: 1) identification and monitoring, 2) cardiovascular disease and management of dyslipidemia, 3) hypertension and use of rennin-angiotensin-aldosterone system blockade and mineralocorticoid receptor blockade, 4) glycemia measurement, hypoglycemia, and drug therapies, 5) nutrition and general care in advanced-stage chronic kidney disease, 6) children and adolescents, and 7) multidisciplinary approaches and medical home models for health care delivery.
Experts concluded that high-risk populations merit special attention to help lower rates of type 2 diabetes and DKD. They also agreed that new DKD therapies are needed to improve clinical outcomes, but they also must be accompanied by better methods for health care delivery and implementation to be effective. The issues and research recommendations identified by this conference hopes to pave the way for advancing care and improving life for patients with DKD.
The National Kidney Foundation, the American Diabetes Association, and the American Society of Nephrology have collaborated and developed a consensus conference that brought together experts in nephrology and endocrinology to review current practices, and to identify knowledge gaps, research opportunities and ways to improve clinical outcomes related to kidney disease in diabetes.
Approximately 50% of new kidney failure cases are caused by diabetes and it is estimated that more than 60% of dialysis patients have diabetes.